CYTK Dividend History & Analysis | N/A Yield
CYTK has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,397 M | 13.4% | 7.37% |
| ABBV | 393,809 M | 3.62% | 9.74% |
| GILD | 150,721 M | 2.52% | 6.73% |
| AMGN | 174,694 M | 2.87% | 4.98% |
| HLN | 44,084 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,397 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 44,084 M | 51.0% | 100% |
| AMGN | 174,694 M | 8.90% | 100% |
| ABBV | 393,809 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare CYTK Dividends with its Peer-Group
3.62% Yield
2.87% Yield
2.52% Yield
1.74% Yield
CYTK Dividend History: as of December 2025
No dividends paid yet.CYTK Dividend FAQ
Cytokinetics Inc. (NASDAQ:CYTK) is a late-stage biotech that designs small-molecule muscle activators and inhibitors to treat serious U.S. diseases. Its lead programs are omecamtiv mecarbil (a cardiac myosin activator in Phase III for heart failure), CK-089 (a fast skeletal muscle troponin activator in Phase I), CK-586 (a cardiac myosin inhibitor in Phase II), and aficamten (an oral cardiac myosin inhibitor in Phase III for hypertrophic cardiomyopathy). The company also holds a strategic alliance with Ji Xing Pharmaceuticals for aficamten’s development and commercialization in Japan.
What is the Dividend Yield of CYTK?
As of December 2025, CYTK`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 63.29.Does CYTK pay a dividend?
As of December 2025 CYTK does not pay a dividend.How often does CYTK pay dividends?
Over the last 12 months, CYTK has issued dividend payments.CYTK dividend forecast
Based on historical data, the forecasted dividends per share for CYTK for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will CYTK pay dividends in 2025?
The next Ex-Dividend date for Cytokinetics (CYTK) is currently unknown.What is the next Ex-Dividend Date for CYTK?
The next Ex-Dividend date for Cytokinetics (CYTK) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CYTK?
CYTK's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CYTK?
CYTK's 5-Year Yield on Cost is -%. If you bought CYTK's shares at 20.95 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CYTK?
CYTK Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CYTK have a good Dividend Yield?
CYTK`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CYTK?
The Dividend Payout Ratio of CYTK is unknown.What is the Dividend Rating of CYTK?
CYTK`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-12 04:37